TNFSF10 and plasma cell myeloma: Moreover, Ciavarella et al. [45] demonstrated in vitro that TRAIL-expressing adipose-derived MSCs could not only directly induce myeloma cell death but also synergistically potentiate the anti-myeloma activity of Bortezomib.